Calculating The Indirect Costs Of Adult Pneumococcal Disease And The Rate Of Return To The 13-Valent Pneumococcal Conjugate Vaccine (PCV13) In Older Adults, With An Application To Denmark
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2302
https://www.valueinhealthjournal.com/article/S1098-3015(17)32636-0/fulltext
Title :
Calculating The Indirect Costs Of Adult Pneumococcal Disease And The Rate Of Return To The 13-Valent Pneumococcal Conjugate Vaccine (PCV13) In Older Adults, With An Application To Denmark
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32636-0&doi=10.1016/j.jval.2017.08.2302
First page :
A787
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2123